A kinesin signaling complex mediates the ability of GSK-3β to affect mood-associated behaviors

Lithium has been the gold standard in the treatment of bipolar disorder (BPD) for 60 y. Like lithium, glycogen synthase kinase 3 (GSK-3) inhibitors display both antimanic-like and antidepressant-like effects in some animal models. However, the molecular mechanisms of both lithium and GSK-3 inhibitor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Du, Jing, Wei, Yanling, Liu, Lidong, Wang, Yun, Khairova, Rushaniya, Blumenthal, Rayah, Tragon, Tyson, Hunsberger, Joshua G., Machado-Vieira, Rodrigo, Drevets, Wayne, Wang, Yu Tian, Manji, Husseini K.
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2010
Assuntos:
Biological Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2895136/
https://ncbi.nlm.nih.gov/pubmed/20534517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0913138107
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados